Currently out of the existing stock ratings of Yale Jen, 20 are a BUY (100%).

Yale Jen

Work Performance Price Targets & Ratings Chart

Analyst Yale Jen, currently employed at LAIDLAW, carries an average stock price target met ratio of 42.86% that have a potential upside of 76.34% achieved within 300 days.

Yale Jen’s has documented 37 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AFMD, Affimed NV at 12-Jun-2024.

Wall Street Analyst Yale Jen

Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $10 was fulfilled within 31 days with a profit of $3.45 (52.67%) receiving and performance score of 16.99.

Average potential price target upside

of $14.48 (34.35%) on IONS (IONIS PHARMACEUTICALS).
of $18.33 (88.68%) on SLNO (SOLENO THERAPEUTICS).

ARCT Arcturus Therapeutics Holdings CRIS Curis VINC Vincerx Pharma IONS Ionis Pharmaceuticals EVFM Evofem Biosciences TCRT Alaunos Therapeutics SLNO Soleno Therapeutics AFMD Affimed NV EYPT Eyepoint Pharmaceuticals MEIP MEI Pharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ed Arce (HC WAINWRIGHT)